You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

Adjuvant Radiotherapy in Women with Stage I Endometrial Cancer

ID: 4-10 Aug 2013
Type of Content: Guidelines & Advice, Clinical
Document Status: Education and Information
Members of the Gynecology Cancer Disease Site Group

Patient Population

Women with newly diagnosed stage I endometrial cancer who have undergone surgery, either complete surgical staging or total abdominal hysterectomy and bilateral salpingo-oophorectomy.

Of interest are outcomes reported by risk of recurrence: low risk (stage IA, IB, grades 1 & 2), intermediate risk (stage IC, grades 1 & 2, or stage IA, IB, grade 3), or high risk (stage IC, grade 3).

Research Question(s)

What is the role of adjuvant radiotherapy in women with stage I endometrial cancer? Specifically, are there subgroups of patients with stage I endometrial cancer who benefit from adjuvant radiotherapy? If so, which radiotherapy treatment is recommended?

Outcomes of interest are survival, pelvic control, ultimate pelvic control, and toxicity.

pdf download Full Report (PDF) (818.26 KB)